UroGen Pharma Ltd. (URGN)

Typically moves ±7.48% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-10 APPROXIMATE

UroGen Pharma Ltd. (URGN) has reported earnings 28 times since Feb 28, 2019. The stock moves an average of ±7.48% the day after reporting, closing higher 60.7% of the time. Its largest post-earnings gain was +21.91% (Nov 06, 2025) and its largest decline was -22.95% (Nov 15, 2021). The next earnings report is predicted for 2026-08-10 (approximate).

Earnings reactions

How URGN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.48%

Positive %

60.7%

Negative %

39.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 06, 2026	☀ PRE	+9.86%	open_in_new
Mar 02, 2026	☀ PRE	-12.35%	open_in_new
Nov 06, 2025	☀ PRE	+21.91%	open_in_new
Aug 07, 2025	☀ PRE	-7.1%	open_in_new
May 12, 2025	☀ PRE	+7.32%	open_in_new
Mar 10, 2025	☀ PRE	+1.02%	open_in_new
Nov 06, 2024	☀ PRE	+0.25%	open_in_new
Aug 13, 2024	☀ PRE	+3.1%	open_in_new
May 13, 2024	☀ PRE	+2.59%	open_in_new
Mar 14, 2024	☀ PRE	-17.97%	open_in_new
Nov 14, 2023	☀ PRE	-0.68%	open_in_new
Aug 10, 2023	☀ PRE	+2.46%	open_in_new
May 11, 2023	☀ PRE	+8%	open_in_new
Mar 22, 2023	☽ POST	+2.33%	open_in_new
Nov 10, 2022	☀ PRE	-16.32%	open_in_new
Aug 11, 2022	☀ PRE	-6.51%	open_in_new
May 10, 2022	☀ PRE	+5.97%	open_in_new
Mar 21, 2022	☀ PRE	+0.11%	open_in_new
Nov 15, 2021	☀ PRE	-22.95%	open_in_new
Aug 04, 2021	☀ PRE	-2.61%	open_in_new
May 13, 2021	☀ PRE	-15.31%	open_in_new
Mar 18, 2021	☀ PRE	-7.44%	open_in_new
Nov 09, 2020	☀ PRE	+4.98%	open_in_new
Aug 10, 2020	☀ PRE	+14.08%	open_in_new
Nov 12, 2019	☀ PRE	+13.58%	open_in_new
Aug 09, 2019	☀ PRE	-1.69%	open_in_new
May 09, 2019	☀ PRE	+0.61%	open_in_new
Feb 28, 2019	☀ PRE	+0.26%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.48%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 17 →

Funds holding

$183094908

Total value held

Buying

10 added · 4 reduced

Blackrock, Inc.

$51163295 +9.40%

Toronto Dominion Bank

$47048518 NEW BUY

Morgan Stanley

$46029492 -0.11%

State Street Corp

$15717684 +8.27%

Goldman Sachs Group Inc

$10761534 +30.19%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260710	open_in_new SEC.gov
144	20260709	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov

Frequently asked about URGN earnings

When does UroGen Pharma Ltd. report earnings next? expand_more

UroGen Pharma Ltd. (URGN)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does URGN stock move after earnings? expand_more

Over 28 reports, URGN has moved an average of ±7.48% the session after earnings, closing higher 60.7% of the time.

What was URGN's biggest post-earnings move? expand_more

URGN's largest post-earnings gain on record was +21.91% on Nov 06, 2025, and its largest decline was -22.95% on Nov 15, 2021.

Where can I find UroGen Pharma Ltd.'s SEC filings? expand_more

All of UroGen Pharma Ltd.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.